Cobb syndrome
| Cobb syndrome | |
|---|---|
| Synonyms | Cutaneomeningospinal angiomatosis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Back pain, neurological deficits, skin lesions |
| Complications | Paralysis, bladder dysfunction, bowel dysfunction |
| Onset | Childhood or adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Congenital |
| Risks | Spinal cord vascular malformations |
| Diagnosis | MRI, CT scan, angiography |
| Differential diagnosis | Sturge-Weber syndrome, Klippel-Trenaunay syndrome |
| Prevention | N/A |
| Treatment | Surgery, embolization, radiotherapy |
| Medication | N/A |
| Prognosis | Variable, depends on extent of neurological involvement |
| Frequency | Rare |
| Deaths | N/A |
A rare congenital disorder involving vascular malformations
Cobb syndrome, also known as cutaneomeningospinal angiomatosis, is a rare congenital disorder characterized by the presence of vascular malformations affecting the skin, spinal cord, and vertebrae. This condition is named after Dr. Stanley Cobb, who first described it in 1915.
Presentation[edit]
Cobb syndrome typically presents with a combination of cutaneous and spinal manifestations. The hallmark of the condition is the presence of a cutaneous hemangioma or vascular malformation on the skin, usually located on the back. This skin lesion is often associated with underlying spinal cord and vertebral involvement.
Cutaneous Manifestations[edit]
The skin lesions in Cobb syndrome are usually present at birth or appear in early childhood. They are typically red or purple in color and may vary in size. These lesions are often located in the midline of the back, corresponding to the level of the spinal cord involvement.
Neurological Manifestations[edit]
The neurological symptoms of Cobb syndrome arise from the involvement of the spinal cord. Patients may experience neurological deficits such as weakness, sensory loss, or paralysis in the areas of the body below the level of the spinal lesion. The severity of these symptoms can vary depending on the extent of the spinal cord involvement.
Pathophysiology[edit]
Cobb syndrome is caused by the presence of abnormal blood vessels, known as arteriovenous malformations (AVMs), that affect the skin, spinal cord, and vertebrae. These AVMs can lead to increased blood flow and pressure in the affected areas, resulting in damage to the spinal cord and surrounding structures.
Diagnosis[edit]
The diagnosis of Cobb syndrome is based on the clinical presentation and imaging studies. Magnetic resonance imaging (MRI) of the spine is the preferred method for visualizing the spinal cord and identifying any vascular malformations. Angiography may also be used to assess the blood vessels and confirm the presence of AVMs.
Treatment[edit]
The management of Cobb syndrome involves addressing both the cutaneous and neurological components of the disorder. Treatment options may include:
- Surgical intervention: In some cases, surgery may be necessary to remove or reduce the size of the vascular malformations, particularly if they are causing significant neurological symptoms.
- Endovascular therapy: This minimally invasive procedure involves the use of catheters to deliver agents that can block or reduce blood flow to the AVMs.
- Symptomatic management: Physical therapy and rehabilitation may be required to manage neurological deficits and improve the patient's quality of life.
Prognosis[edit]
The prognosis for individuals with Cobb syndrome varies depending on the severity of the spinal cord involvement and the success of treatment interventions. Early diagnosis and appropriate management are crucial for improving outcomes and minimizing neurological complications.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian